Article Figures & Tables
Tables
Description Definition Why the referral was clearly indicated Poorly controlled HbA1C HbA1C ≥ 8.5%. The HbA1C test reflects the percentage of hemoglobin (protein in red blood cells) coated in sugar. Higher HbA1C values indicate poorer blood glucose control and higher risk of complications. Diabetes control is sufficiently poor that improvement is unlikely without substantial changes to therapy, which often requires a diabetes specialist and multidisciplinary team. Elevated HbA1C and taking 3 or more non-insulin antihyperglycemic agents HbA1C ≥ 7.5% and taking 3 or more antihyperglycemic agents Patients who fit this description have type 2 diabetes and need to start insulin. Traditionally, initiation of insulin in type 2 diabetes has been an activity for specialists. While this can be done safely and effectively in primary care it is not yet standard of care in all places. Elevated HbA1C and on insulin Hospital admission or ED visit for a diabetes-specific ambulatory care sensitive condition in prior year HbA1C ≥ 7.5% and taking insulin (regardless of use of antihyperglycemic agents) A hospital admission or ED visit with 1 of the following ICD-10 codes indicating hyperglycemic or hypoglycemic events for type 1, type 2 and other diabetes in the year before specialist visit: E10.0 (type 1 with coma)
E10.63 (type 1 with hypoglycemia)
E11.0 (type 2 with coma)
E11.63 (type 2 with hypoglycemia)
E13.0 (other specified with coma)
E13.63 (other specified with hypoglycemia)
E14.0 (unspecified with coma)
E14.63 (unspecified with hypoglycemia)
Patients who fit this description have type 1 diabetes or type 2 diabetes requiring further intensification of therapy. These represent potentially life-threatening events because of significant gaps in, or adverse effects of, diabetes therapy that may require substantial changes to therapy by a specialist and multidisciplinary team. Note: ED = emergency department, HbAIC = hemoglobin A1C, ICD-10 = International Statistical Classification of Diseases and Related Health Problems, 10th revision.
↵* Definitions supported by the Canadian Diabetes Association’s 2013 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada21 and expert committee opinion.
- Table 2:
Characteristics of patients with diabetes with a specialist physician visit for diabetes, by physician payment model
Characteristic Total
n = 23 954Fee for service
n = 21 218Salary based
n = 2736Standardized difference Age, yr, mean ± SD 56.3 ± 15.4 56.9 ± 14.8 52.3 ± 18.5 27.2 18–29 yr, no. (%) 1495 (6.2) 1076 (5.1) 419 (15.3) > 29 yr, no. (%) 22 459 (93.8) 20 142 (94.9) 2317 (84.7) Female, no. (%) 10 878 (45.4) 9430 (44.4) 1448 (52.9) 17.0 First Nations status, no. (%) 886 (3.7) 691 (3.3) 195 (7.1) 17.5 Socioeconomic status, no. (%) Quintile 1 (lowest) 5614 (24.1) 5030 (24.3) 584 (22.5) 5.7 Quintile 2 5563 (23.8) 4982 (24.0) 581 (22.4) 5.4 Quintile 3 4365 (18.7) 3883 (18.7) 482 (18.6) 1.8 Quintile 4 4041 (17.3) 3568 (17.2) 473 (18.2) 1.3 Quintile 5 (highest) 3748 (16.1) 3274 (15.8) 474 (18.3) 5.1 Rural (community < 1000 people), no. (%) 1764 (7.4) 1425 (6.7) 339 (12.4) 19.4 Primary care attachment (relational continuity),* no. (%) Infrequent 2651 (11.1) 2279 (10.7) 372 (13.6) 8.7 Low 3185 (13.3) 2799 (13.2) 386 (14.1) 2.7 Medium 7021 (29.3) 6211 (29.3) 810 (29.6) 0.7 High 11 097 (46.3) 9929 (46.8) 1168 (42.7) 8.3 Diabetes illness severity Baseline HbA1c, mean ± SD 8.4 ± 2.0 8.4 ± 1.9 8.5 ± 2.1 7.6 Proportion with sustained HbA1c > 9%, no. (%) 5413 (22.6) 4744 (22.4) 669 (24.5) 4.9 Duration of diabetes, yr, mean ± SD 8.9 ± 6.1 8.9 ± 6.0 9.1 ± 6.2 2.4 Admissions to hospital or visits to EDs for diabetes-specific ACSC in year before visit,† mean ± SD 0.35 ± 0.97 0.32 ± 0.86 0.53 ± 1.5 13.2 Patients with 1 hospital or ED visit for diabetes-specific ACSC in year before visit,† no. (%) 3888 (16.2) 3354 (15.8) 534 (19.5) 5.8 Patients with 2 or more hospital or ED visits for diabetes-specific ACSC in year before visit,† no. (%) 1452 (6.1) 1167 (5.5) 285 (10.4) 5.8 Comorbidities CKD, no. (%) 8993 (37.5) 7897 (37.2) 1096 (40.1) 5.8 More advanced CKD,‡ no. (%) 1345 (15.0) 1158 (14.7) 187 (17.1) 6.6 1 comorbidity only (including diabetes),§ no. (%) 3848 (16.1) 3343 (15.8) 505 (18.5) 13.2 2 comorbidities,§ no. (%) 6063 (25.3) 5474 (25.8) 589 (21.5) 10.1 3 or 4 comorbidities,§ no. (%) 9572 (40.0) 8558 (40.3) 1014 (37.1) 6.7 ≥ 5 or more comorbidities,§ no. (%) 4471 (18.7) 3843 (18.1) 628 (23.0) 12.0 Note: ACSC = ambulatory care sensitive condition, CKD = chronic kidney disease, ED = emergency department, SD = standard deviation.
↵* Primary care attachment (also called relational continuity) categories are defined as infrequent (1 or 2 primary care visits), high (> 75% of patients’ 3 or more primary care visits made to the same physician), medium (50%–75% of 3 or more visits made to the same physician), and low (< 50% of visits made to any 1 primary care physician).
↵† Diabetes-specific ambulatory care sensitive conditions include coma, acidosis and hypoglycemia and no mention of complications for type 1, type 2, other specified and unspecified diabetes.
↵‡ More advanced CKD is defined as estimated glomerular filtration rate (eGFR) < 30 mL/min/1.73 m2, eGFR < 45 mL/min/1.73 m2 with moderate or severe albuminuria, or eGFR < 60 mL/min/1.73 m2 with severe albuminuria. Moderate albuminuria is defined as albumin-creatinine ratio (ACR) 30–300 mg/g, protein-creatinine ratio (PCR) 150–500 mg/g, urine dipstick (UDIP) 1+ and severe albuminuria is defined as ACR > 300 mg/g, PCR > 500 mg/g, UDIP ≥ 2+.
↵§ Comorbidities included diabetes, CKD and 28 other chronic conditions with validated administrative data algorithms.20
- Table 3:
Characteristics of specialist physicians seeing patients with diabetes, by physician payment model
Characteristic Fee for service
n = 193Salary based
n = 109Physician type* Diabetes specialist, no. (%) 12 (6.2) 11 (10.1) Internal medicine specialist, no. (%) 165 (85.5) 79 (72.5) Kidney specialist, no. (%) 16 (8.3) 19 (17.4) Years practising in Alberta since 1994, mean ± SD 7.5 ± 7.0 8.7 ± 5.6 Clinical workload† Lowest tertile, no. (%) 46 (23.8) 26 (23.9) Mid tertile, no. (%) 79 (40.9) 79 (72.5) Highest tertile, no. (%) 68 (35.2) 4 (3.7) Location‡ Urban zone 1, no. (%) 119 (61.7) 49 (45.0) Urban zone 2, no. (%) 74 (38.3) 60 (55.1) Clinic location Teaching hospital, no. (%) 21 (11) 60 (55) Large urban hospital, no. (%) 64 (33) 20 (18) Suburban/rural hospital, no. (%) 10 (5) 0 (0) Community ambulatory centre, no. (%) 31 (16) 16 (15) Missing,§ no. (%) 67 (34) 13 (12) Note: SD = standard deviation.
↵* Diabetes specialists are endocrinologists and internal medicine physicians who see > 50 patients with diabetes each year and for whom > 30% of claims are for outpatient diabetes care.
↵† Clinical workload is defined as the following: tertile 1 = fewer than 94 days billing per year, tertile 2 = 95–221 days billing per year, tertile 3 = 222–365 days billing per year.
↵‡ The province of Alberta has 2 large urban areas: the cities of Calgary and Edmonton.
↵§ Includes patient home visits and missing clinic locations.
- Table 4:
Proportion of patients with a clearly indicated visit to a diabetes specialist, by age of patient and physician payment model
Characteristic Total, no. (%)
n = 11 130Fee for service, % (95% CI)
n = 9988Salary based, % (95% CI)
n = 1142Comparison of patients seen by salary-based physicians with patients seen by fee-for-service physicians, risk ratio (95% CI) p value All patients Visit with a clear indication to a diabetes specialist* 6297 (56.6) 55.6 (54.1–57.1) 65.2 (60.7–70.1) 1.17 (1.1–1.3) < 0.001 Poorly controlled HbA1C† 4442 (39.9) 38.8 (37.6–40.0) 49.9 (46.0–54.2) 1.29 (1.2–1.4) < 0.001 Elevated HbA1C and on 3 or more diabetes medications‡ 970 (8.7) 9.2 (8.6–9.8) 4.5 (3.4–5.9) 0.49 (0.4–0.6) < 0.001 Elevated HbA1C and on insulin§ 4058 (36.5) 35.1 (34.0–36.3) 48.4 (44.6–52.6) 1.38 (1.3–1.5) < 0.001 Hospital or ED visits for a diabetes-specific ACSC in the year before the specialist visit¶ 162 (1.5) 1.3 (1.1–1.5) 3.2 (2.3–4.4) 2.50 (1.7–3.6) < 0.001 Age 18–29 yr n = 906 n = 610 n = 296 Visit with a clear indication to a diabetes specialist* 560 (61.8) 61.0 (55.1–67.5) 63.5 (55.1–73.3) 1.04 (0.9–1.2) 0.7 Poorly controlled HbA1C† 439 (48.5) 47.7 (42.5–53.5) 50.0 (42.6–58.7) 1.05 (0.9–1.3) 0.6 Elevated HbA1C and on 3 or more diabetes medications‡ 3 (0.3) 0.33 (0.1–1.3) 0.34 (0.1–2.4) 1.03 (0.1–11.4) 1.0 Elevated HbA1C and on insulin§ 455 (50.2) 47.9 (42.7–53.7) 55.1 (47.2–64.2) 1.15 (1.0–1.4) 0.2 Hospital or ED visits for a diabetes-specific ACSC in the year before the specialist visit¶ 22 (2.4) 2.5 (1.5–4.1) 2.4 (1.1–5.0) 0.96 (0.4–2.4) 0.9 Age > 29 yr n = 10 224 n = 9378 n = 846 Visit with a clear indication to a diabetes specialist* 5737 (56.1) 55.2 (53.8–56.8) 65.8 (60.6–71.5) 1.19 (1.1–1.3) < 0.001 Poorly controlled HbA1C† 4003 (39.2) 38.2 (37.0–39.5) 49.9 (45.3–54.9) 1.31 (1.2–1.5) < 0.001 Elevated HbA1C and on 3 or more diabetes medications‡ 967 (9.5) 9.8 (9.2–10.4) 5.9 (4.5–7.8) 0.60 (0.5–0.8) < 0.001 Elevated HbA1C and on insulin§ 3603 (35.2) 34.3 (33.1–35.5) 46.1 (41.7–50.9) 1.35 (1.2–1.5) < 0.001 Hospital or ED visits for a diabetes-specific ACSC in the year before the specialist visit¶ 140 (1.4) 1.18 (0.98–1.4) 3.4 (2.4–4.9) 2.90 (1.9–4.4) < 0.001 Note: ACSC = ambulatory care sensitive condition, CI = confidence interval, ED = emergency department.
↵* Diabetes specialists were defined as those seeing > 50 patients with diabetes each year and for whom > 30% of claims were for outpatient diabetes treatment.
↵† HbA1c > 8.5.
↵‡ HbA1c > 7.5 and taking 3 or more non-insulin antihyperglycemic agents.
↵§ HbA1c > 7.5 and on insulin.
↵¶ Hypoglycemic- or hyperglycemic-related incidents (ICD-10 [International Statistical Classification of Diseases and Related Health Problems, 10th revision] codes E10.0 [type 1 with coma], E10.63 [type 1 with hypoglycemia], E11.0 [type 2 with coma], E11.63 [type 2 with hypoglycemia], E13.0 [other specified with coma], E13.63 [other specified with hypoglycemia], E14.0 [unspecified with coma] and E14.63 [unspecified with hypoglycemia]).